Value of brain natriuretic peptide in pulmonary arterial hypertension
MH Williams, JG Coghlan(Royal Free London NHS Foundation Trust), Akram, Devika Nair(University of California, San Francisco), CP Denton(The Royal Free Hospital), Colette Smith(MRC Clinical Trials Unit at UCL), CM Black, CE Handler
UCL Discovery (University College London)
September 1, 2005
Cited by 1
Related Papers
Trends in underlying causes of death in people with HIV from 1999 to 2011 (D:A:D): a multicohort collaboration
|The Lancet|2014|930
Prevalence and outcome in systemic sclerosis associated pulmonary arterial hypertension: application of a registry approach
|Annals of the Rheumatic Diseases|2003|769
Bosentan treatment of digital ulcers related to systemic sclerosis: results from the RAPIDS-2 randomised, double-blind, placebo-controlled trial
|Annals of the Rheumatic Diseases|2010|503
An updated prediction model of the global risk of cardiovascular disease in HIV-positive persons: The Data-collection on Adverse Effects of Anti-HIV Drugs (D:A:D) study
|European Journal of Preventive Cardiology|2015|237